Bioteque Corporation (TPEX:4107)
Taiwan · Delayed Price · Currency is TWD 125.00
0.00 (0.00%)
At close: Dec 4, 2025
Bioteque Market Cap
Bioteque has a market cap or net worth of 8.63 billion as of December 5, 2025. Its market cap has decreased by -0.40% in one year.
Market Cap
8.63B
Enterprise Value
7.75B
Revenue
2.07B
Ranking
n/a
PE Ratio
16.73
Stock Price
125.00
Market Cap Chart
Since November 3, 2004, Bioteque's market cap has increased from 442.84M to 8.63B, an increase of 1,848.26%. That is a compound annual growth rate of 15.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 8.66B | 1.21% |
| Dec 31, 2024 | 8.56B | 12.27% |
| Dec 29, 2023 | 7.62B | -1.35% |
| Dec 30, 2022 | 7.73B | -2.62% |
| Dec 30, 2021 | 7.93B | -13.91% |
| Dec 31, 2020 | 9.22B | 1.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 259.78B |
| PharmaEssentia | 189.73B |
| Heron Neutron Medical | 95.61B |
| Lotus Pharmaceutical | 78.24B |
| Bora Pharmaceuticals Co., LTD. | 65.19B |
| Lin BioScience | 34.45B |
| Oneness Biotech | 33.73B |
| Lumosa Therapeutics | 32.34B |